Transbaikalia: The authorities confirmed the insulin deficit

Governor of Transbaikalia Alexander Osipov confirmed the insulin deficit. He told about this during the online broadcast on December 1, answering questions from the residents of the region.

When the residents of Transbaikalia through the call center of broadcasts several times complained that they could not get preferential insulin, Osipov said that "the need for insulin was closed by the regional budget, but within a year it increased due to new patients."

The head of the region noted that according to the local Ministry of Health, only 19 thousand inhabitants needed medicine. But in a year 400 new patients appeared, for whom the ministry was not ready.

"For 2024, the number of insulin recipients that we have in the register has been purchased, absolutely the entire volume. But during the year new patients appear who have a disease, and they also become lobed -reciprocators. Until the end of the year, everyone who needs insulin, according to the regional benefit, will be provided with Osipova as Osipova quoted the administration of the administration of the administration of the administration edges.

Later, the head of the Ministry of Health of the Territory Oksana Nemakina said that patients will begin to receive insulin from December 10.

What patients with diabetes should do, which insulin is vital daily, in anticipation of supplies, officials did not report.

• In 2023, the Russian authorities reduced federal expenses for the purchase of drugs from other countries by 65 billion rubles. This money could be directed to military needs, according to Headway Company and DSM Group analysts. 78.5% of doctors surveyed by the professional community "Doctors of the Russian Federation" in 2024 complained about the shortage of drugs in Russia.
• Since 2022, interruptions with drugs have been constantly arising in the Russian regions. In August, in pharmacies of several remote villages in Kamchatka, medicines ended . The supply of power promised only by September 1. In July, in the Russian regions, HIV-positive patients began to actively complain about interruptions with antiretroviral (ABR) drugs, replacing imported drugs with Russian analogues with serious side effects. Experts say that the budget allocated by the state for antiretroviral Therapy is reduced by a third, despite the fact that the number of patients is growing.
• In the spring of 2024, in 58 Russian regions, the drug "Kalimate" necessary for people on dialysis was disappeared from pharmacies. This is the only potassium sorbent registered in Russia. Since the summer of 2023, parents of patients with diabetes and children with cystic fibrosis complain of interruptions with hemostatic drugs, insulin and consumables for insulin pumps.